Concepedia

Tina deVries

TD

Statistics

Publications

7

Citations

144

H-Index

7

Active since

1996

Affiliations

Osmotica Pharmaceutical (United States)(Current)

University of Toronto

Osmotica Pharmaceutical (Hungary)

Tina deVries is an author at Osmotica Pharmaceutical (United States) specializing in pharmacology, clinical pharmacology, and pharmacy.

Publications per year

1996–2022

7

Publications

7

Bioavailability and Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets in Healthy Volunteers: Results from Three Randomized, Crossover, Open-Label, Phase 1 Studies

Tina deVries, Angela Dentiste, Lata Handiwala et al. · Neurology and Therapy · 2019 · 24 citations · Full text

, , +17

Results of a phase I/II multi-center investigation of udenafil in adolescents after fontan palliation

David Goldberg, Victor Zak, Bryan H. Goldstein et al. · American Heart Journal · 2017 · 23 citations

, , +2

Pharmacokinetic Comparison of Once-Daily Topical Minocycline Foam 4% vs Oral Minocycline for Moderate-to-Severe Acne.

Terry M. Jones, Herman Ellman, Tina deVries · PubMed · 2017 · 23 citations

, , +14

Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's disease

Robert J. Fontana, Tina deVries, Thomas F. Woolf et al. · British Journal of Clinical Pharmacology · 1998 · 21 citations · Full text

, , +15

Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies

Olivier Rascol, Lars Tönges, Tina deVries et al. · Parkinsonism & Related Disorders · 2022 · 21 citations · Full text

, , +16

1–5 of 7